VitaNova Life Sciences (VNOV) Interest Expenses (2024 - 2025)

VitaNova Life Sciences (VNOV) reported Interest Expenses of $1568.0 for Q2 2025, up 92.87% quarter-over-quarter from $813.0 in Q1 2025.

VitaNova Life Sciences (VNOV) Interest Expenses (2024 - 2025) Analysis & Trends

VitaNova Life Sciences has reported Interest Expenses for 2 years, with the latest figure at $1568.0 in Q2 2025.

For the quarter ending Q2 2025, Interest Expenses changed N/A year-over-year to $1568.0; the trailing twelve-month figure through Jan 2026 stood at $1568.0 (down 46.63% YoY), and the FY2025 full-year result was $4506.0, changed N/A from the prior year.
Interest Expenses for Q2 2025 stood at $1568.0, up from $813.0 in the prior quarter.
The five-year high for Interest Expenses was $2125.0 in Q4 2024, with the low at $813.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int Expense (Qtr)
1	Akso Health	2,315,158.81 Bn	2,315,158.63 Bn	-	-
2	Mckesson	92.76 Bn	89.18 Bn	4.04 Bn	61.00 Mn
3	Cencora	52.82 Bn	50.83 Bn	3.59 Bn	-
4	Cardinal Health	52.17 Bn	48.39 Bn	2.50 Bn	101.00 Mn
5	Henry Schein	9.19 Bn	9.71 Bn	1.07 Bn	39.00 Mn
6	Accendra Health	246.88 Mn	-90.00 Mn	312.39 Mn	32.35 Mn
7	Edap Tms	161.92 Mn	146.92 Mn	8.15 Mn	-
8	111	107.47 Mn	25.61 Mn	23.58 Mn	-1.62 Mn
9	Cosmos Health	9.42 Mn	7.26 Mn	1.38 Mn	423,229.00
10	VitaNova Life Sciences	-	-	316,343.00	-

Download Data